Single-agent temozolomide may be an effective option for late adjuvant therapy in patients with melanoma.


Tas F., Erturk K.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, cilt.27, sa.1, ss.40-45, 2021 (SCI-Expanded) identifier identifier identifier